Preview Newsletter
Cosmetic Talc Litigation Media Coverage November 09, 2016
-
Study says baby powder causes ovarian cancer, but how true is this?
Nov 8, 2016 | Latin Post
By Anna Gean
Talcum powder, popularly known as baby powder, is used for keeping skin dry and prevent diaper rashes for babies. -
Johnson & Johnson talc powder lawsuits far from over
Nov 9, 2016 | The Vanguard
By Althea Estrella
After losing for the third time in a row, Johnson & Johnson is hoping to stop its series of defeats in court by trying to have the rest of its talc powder lawsuits heard in a different court. -
Johnson & Johnson (NYSE:JNJ) seeks to move talc lawsuits
Nov 8, 2016 | Benchmark Monitor
Johnson & Johnson (NYSE:JNJ) said that, it plans to make its case before the Missouri Court of Appeals that causes related to lawsuits alleging the company’s talcum powder caused cancer should be moved out of St. Louis courts.
Client Attorney Privileged/Attorney Work Product/At Request of Counsel
US Coverage
-
Study says baby powder causes ovarian cancer, but how true is this?
Nov 8, 2016 | Latin Post
By Anna Gean
Talcum powder, popularly known as baby powder, is used for keeping skin dry and prevent diaper rashes for babies. Baby powder is mined from rock deposits like any other valuable mineral, but only the highest grade of talc can be used for consumption. Elements mainly needed for baby power include magnesium, silicon, and oxygen, but sometimes its natural form contains contains asbestos - a substance that can cause lung cancer when inhaled.
News Max has reported that some kinds of baby powder are asbestos-free, but researchers still keep on finding more evidence. According to American Cancer Society, talcum powder might cause ovarian cancer if the particles are applied to the genital area or in any sanitary napkins or condoms. But these studies are not still proven yet because the researchers have long relied on the case of one patient, whose cancer has been associated with using baby powder.
On the other hand, the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO) classified talc as a substance "carcinogenic to humans" due to asbestos. However, talc is deemed "not classifiable as to carcinogenicity in humans" if it doesn't contain asbestos. Dr. Hal Lawrence, chief executive officer (CEO) of the American Congress of Obstetricians and Gynecologists, said that several decades of medical research doesn't support the hypothesis that talcum powder can cause ovarian cancer.
According to American Cancer Society, any obstetrician-gynecologist isn't recommended to use talcum powder or vaginal sprays because of the potential of triggering discomfort or pain. Cancer researchers said that they can't find any definite evidence proving that talcum powder can cause ovarian cancer.
The only risk factor for ovarian cancer is on genetics - whether it runs in the patients' families or caused by a BRCA1 mutation. There might be a risk using talcum powder but only a small one nonetheless that's hard to measure, Dr. Steven Nord said.
Dr. Don Dizon stated that the best thing those who think that talcum powder can cause ovarian cancer should do is to stop its use when in doubt.
http://www.latinpost.com/articles/126066/20161108/study-says-baby-powder-causes-ovarian-cancer-but-how-true-is-this.htm
-
Johnson & Johnson talc powder lawsuits far from over
Nov 9, 2016 | The Vanguard
By Althea Estrella
After losing for the third time in a row, Johnson & Johnson is hoping to stop its series of defeats in court by trying to have the rest of its talc powder lawsuits heard in a different court.
Johnson & Johnson is hoping that the $67.5 million verdict handed down by the jury in October will be the last of the string of multimillion dollar-verdicts from lawsuits claiming that the company’s talc-based products can cause ovarian cancer in women.
The company hopes to move the cases to a different court, arguing that the St. Louis state court has no jurisdiction over the cases.
Legal counsels for the company have earlier tried to argue that neither the plaintiffs nor Johnson & Johnson have strong ties in St. Louis, citing that most of the complainants are not even from the same city — which should have left no valid reason for the case to be heard in the St. Louis state court.
But the judge rejected that argument.
Lawyers representing the company have also tried to argue that the plaintiffs’ lawyers have exerted tremendous efforts in tainting the jury, spending a total of $10 million on local and national television advertisements last year, and that they had many of these advertisements run in St. Louis during the same period.
The judge also rejected this argument.
Johnson & Johnson is hoping that the Missouri Court of Appeals will decide differently, although its legal counsel is planning on using the same arguments citing the court’s jurisdiction.
A majority of the 2,500 other similar talc powder claims against Johnson & Johnson have been filed in the same court, which appears to be one of a handful other courts in the U.S. that are popular in consumer lawsuits.
If the Missouri Court of Appeals finds that the St. Louis court has no jurisdiction over the cases, the said cases will have to be filed somewhere else.
A state court in New Jersey, where a number of other similar claims were filed by complainants, has previously disqualified the experts testifying in behalf of the plaintiffs, on the grounds that the scientific basis being cited by the experts was too speculative.
Johnson & Johnson’s lawyers have attempted to use the same argument in St. Louis, but the judge downright rejected the argument.
With at least 2,500 other cases waiting to be heard, and at the rate that the company is losing money through multimillion dollar settlements and penalties in court, the future may not seem so bright for Johnson & Johnson — unless its legal team is successful in persuading the Missouri Court of Appeals into letting the cases go elsewhere.
https://vanguarddaily.com/johnson-johnson-talc-powder-lawsuits-far-from-over/
-
Johnson & Johnson (NYSE:JNJ) seeks to move talc lawsuits
Nov 8, 2016 | Benchmark Monitor
Johnson & Johnson (NYSE:JNJ) said that, it plans to make its case before the Missouri Court of Appeals that causes related to lawsuits alleging the company’s talcum powder caused cancer should be moved out of St. Louis courts.
On last trading day, Johnson & Johnson (NYSE:JNJ) traded 6.4 Million shares and was closed at $116.66 per share. Company stock is -6.85% away from its one year high and is moving 26.36% ahead of its one year low. Stock monthly performance is recorded as -2.16% while its performance in last one week is 0.58%. JNJ quarterly performance is -4.85% while firm’s price to sale ratio is 4.45 and price to book ratio is 4.41.
Analyst’s Analysis on Johnson & Johnson (NYSE:JNJ)
Number of analysts are eying on this stock and after detailed observation, they have given the stock mean target price of $126.32 while their mean recommendation is 2.40 (1=Buy, 5=sell). The consensus recommendation by Thomson Reuter’s analysts is Outperform and their mean rating for the stock is 2.35 on scale of 1-5.http://www.benchmarkmonitor.com/2016/11/08/johnson-johnson-nysejnj-seeks-to-move-talc-lawsuits/
Client Attorney Privileged/Attorney Work Product/At Request of Counsel
US Coverage
Add recipients
Suggested